desonide

FDA Drug Profile — Desonide

Drug Details

Generic Name
desonide
Brand Names
Desonide
Application Number
NDA019048
Sponsor
Actavis Pharma, Inc.
NDC Codes
3
Dosage Forms
CREAM, LOTION
Routes
TOPICAL
Active Ingredients
DESONIDE

Indications and Usage

1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use : Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: • Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.